Immunization status of the 23-valent pneumococcal polysaccharide vaccine among elderly aged 65 and older in South Korea

被引：0
|
作者：
Kim, Jeong Ah [1 ]
Won, Heehyun [1 ]
Jeong, Na-Young [2 ]
Choi, Nam-Kyong [1 ]
机构：
[1] Ewha Womans Univ, Dept Hlth Convergence, Coll Sci & Ind Convergence, Seoul, South Korea
[2] Ewha Womans Univ, Dept Hlth Convergence, Seoul, South Korea
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2023年 / 32卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
628
引用
收藏
页码：294 / 294
页数：1
相关论文
共 50 条
  • [1] Effectiveness of 23-valent pneumococcal polysaccharide vaccine on diabetic elderly
    Kuo, Chia-Sheng
    Lu, Chia-Wen
    Chang, Yu-Kang
    Yang, Kuen-Cheh
    Hung, Shou-Hung
    Yang, Ming-Ching
    Chang, Hao-Hsiang
    Huang, Chi-Ting
    Hsu, Chih-Cheng
    Huang, Kuo-Chin
    MEDICINE, 2016, 95 (26)
  • [2] Immunogenicity of a 23-valent pneumococcal polysaccharide vaccine in Brazilian elderly
    Simonsen, V
    Brandao, AP
    Brandileone, MCC
    Yara, TI
    Di Fabio, JL
    Lopes, MH
    Jacob, W
    BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH, 2005, 38 (02) : 251 - 260
  • [3] Cost-effectiveness of the 20-valent pneumococcal conjugate vaccine versus the 23-valent pneumococcal polysaccharide vaccine for older adults in South Korea
    Kang, Dong-Won
    Kim, Chae-Rin
    Song, Joon Young
    Park, Sun-Kyeong
    VACCINE, 2024, 42 (04) : 871 - 878
  • [4] Use of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine Among Adults Aged ≥65 Years: Updated Recommendations of the Advisory Committee on Immunization Practices
    Matanock, Almea
    Lee, Grace
    Gierke, Ryan
    Kobayashi, Miwako
    Leidner, Andrew
    Pilishvili, Tamara
    MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT, 2019, 68 (46): : 1069 - 1075
  • [5] Use of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine Among Adults Aged ≥65 Years: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
    Tomczyk, Sara
    Bennett, Nancy M.
    Stoecker, Charles
    Gierke, Ryan
    Moore, Matthew R.
    Whitney, Cynthia G.
    Hadler, Stephen
    Pilishvili, Tamara
    MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT, 2014, 63 (37): : 822 - 825
  • [6] Safety of concomitant administration of 23-valent polysaccharide pneumococcal vaccine and influenza vaccine among the elderly
    Won, Heehyun
    Kim, Jeong Ah
    Jeong, Na-Young
    Choi, Nam-Kyong
    VACCINE, 2024, 42 (13) : 3190 - 3196
  • [7] Safety of concomitant administration of 23-valent polysaccharide pneumococcal vaccine and influenza vaccine among the elderly
    Won, Heehyun
    Kim, Jeong Ah
    Jeong, Na-Young
    Choi, Nam-Kyong
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2023, 32 : 24 - 25
  • [8] The Efficacy of 23-Valent Pneumococcal Polysaccharide Vaccine in Preventing Pneumonia and Invasive Pneumococcal Disease in the Elderly Aged 75 Years and Older in Taiwan
    Hsieh, Meng-Jer
    Tsai, Ying-Huang
    Chang, Chee-Jen
    Wen, Yu-Wen
    Hu, Han-Chung
    Chao, Yen-Nan
    Huang, Yhu-Chering
    Yang, Cheng-Ta
    Huang, Chung-Chi
    CHEST, 2013, 144 (04)
  • [9] HEALTH AND ECONOMIC IMPACT OF 23-VALENT PNEUMOCOCCAL POLYSACCHARIDE VACCINE IN THE OLDER ADULT IMMUNIZATION PROGRAM IN MEXICO
    Parellada, C.
    Castillo, C. A.
    Acevedo, R.
    Owusu-Edusei, K.
    Moreira, T. N. F.
    Rincon-Ponce, J. V. M.
    Cossrow, N.
    Johnson, K. D.
    VALUE IN HEALTH, 2022, 25 (12) : S90 - S90
  • [10] Cost-effectiveness of a 23-valent pneumococcal polysaccharide vaccine immunization programme for the elderly in Shanghai, China
    Zhao, Daijun
    Tobe, Ruoyan Gai
    Cui, Min
    He, Jinchun
    Wu, Bin
    VACCINE, 2016, 34 (50) : 6158 - 6165
12345